Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
Aude Jehl(Centre National de la Recherche Scientifique), Sophie Martin(Centre National de la Recherche Scientifique)
Cited by 30
Related Papers
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
|Cancers|2021|12
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids
|International Journal of Molecular Sciences|2023|12